期刊
JOURNAL OF CLINICAL ONCOLOGY
卷 26, 期 17, 页码 2883-2889出版社
AMER SOC CLINICAL ONCOLOGY
DOI: 10.1200/JCO.2007.15.2702
关键词
-
类别
资金
- NCI NIH HHS [P50 CA058184, P50CA058184] Funding Source: Medline
Lung cancer is the leading cause of cancer death in the world today and is poised to claim approximately 1 billion lives during the 21st century. A major challenge in treating this and other cancers is the intrinsic resistance to conventional therapies demonstrated by the stem/progenitor cell that is responsible for the sustained growth, survival, and invasion of the tumor. Identifying these stem cells in lung cancer and defining the biologic processes necessary for their existence is paramount in developing new clinical approaches with the goal of preventing disease recurrence. This review summarizes our understanding of the cellular and molecular mechanisms operating within the putative cancer-initiating cell at the core of lung neoplasia.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据